Phenotypic and genotypic characterization of canine pyoderma isolates of Staphylococcus pseudintermedius for biofilm formation

Biofilm-forming ability is increasingly being recognized as an important virulence factor in several Staphylococcus species. This study evaluated the biofilm-forming ability of sixty canine derived clinical isolates of S. pseudintermedius, using three phenotypic methods, microtiter plate test (MtP), Congo red agar method (CRA) and tube adherence test, and the presence and impact of biofilm-associated genes (icaA and icaD). The results showed that icaA and icaD genes were detected concomitantly in 55 (91.7%) of 60 isolates. A majority (88.3%) of the strains screened had matching results by the tube adherence test, MtP and PCR analysis. Better agreement (95%) was found between the PCR-based analysis and the CRA. Results of the icaA and icaD gene PCRs showed good agreement with CRA results, with a kappa of 0.7. Comparing the phenotypic methods, the statistical analysis showed that the agreement among the phenotypical tests using categorical data was generally good. Considering two classes (biofilm producer and biofilm non-producer), the percentage of matching results between the CRA method and the tube adherence test and between the CRA method and the MtP was 93.3%. A concordance of 100% was revealed between the MtP and the tube adherence test. The results indicate a high prevalence of the ica genes within S. pseudintermedius isolates, and their presence is associated with in vitro formation of a biofilm. A combination of phenotypic and genotypic tests is recommended for investigating biofilm formation in S. pseudintermedius.     

耐受自身代谢产物及耐二甲基亚砜红霉素高产菌株的选育

为提高红霉素发酵单位,考察了二甲基亚砜(DMSO)添加时间和体积分数对红霉素合成的影响,采用筛选自身代谢产物突变株的方法,将突变株进行常压室温等离子体(ARTP)诱变和耐受高浓度DMSO处理。结果显示,在36 h向发酵瓶中添加30000μg/m L红霉素,筛选得到化学效价比对照提高22.4%的菌株。DMSO最适添加时间为发酵48 h,最适添加剂量为0.2%,其可提高发酵单位10.1%。     

大肠杆菌生物被膜与耐药性的关系

生物被膜的形成是大肠杆菌引起消化道反复难治性感染的重要因素。大肠杆菌形成生物被膜后使感染易于慢性化、控制困难,具有高度耐药性的同时还能逃避免疫系统的攻击和抗菌药物的杀伤作用。生物被膜的耐药机制主要包括营养限制、渗透障碍、表型结构学说等。现就大肠杆菌生物被膜的形成、耐药机制及其防治策略等研究现状做一综述。     

RNA-Seq技术在瘤胃微生物研究中的应用进展

反刍动物瘤胃内多种多样的微生物组成一个复杂的微生态系统,它们在瘤胃内物质消化过程中发挥重要作用。RNA-Seq技术的出现为反刍动物瘤胃微生物的研究提供了前所未有的机遇。本文主要从新一代高通量测序技术出发,阐述RNA-Seq技术在瘤胃微生物代谢酶特性、瘤胃微生物的多样性、瘤胃微生物新功能基因方面的应用,以期为瘤胃微生物的研究提供参考。     

基于全基因组填充重测序关联分析鉴别影响苏山猪初生体尺与乳头数性状的遗传位点

旨在鉴别影响苏山猪初生体尺和乳头数性状的遗传位点,开发可用于辅助育种的分子标记,为苏山猪生长和繁殖性能的持续选育提供理论基础。本试验对269头苏山猪初生仔猪(出生后24 h内)的体尺和乳头数表型进行测定,并采集耳组织样品。基于全基因组重测序及基因型填充策略,利用全基因组关联分析(genome-wide association study, GWAS)和群体分化指数(fixation index,Fst)的方法挖掘与目的性状强关联位点,并对位置功能候选基因开展GO和KEGG分析,确定最有可能的主效基因。本研究共鉴别到4个候选位点,分布在13、14和X染色体上,其中与初生体尺性状显著关联的位点有2个,与乳头数性状显著关联的位点有2个。本研究筛选出1个与体长性状相关的候选基因ACTA2;1个与胸围性状相关的候选基因COL4A6;3个与乳头数性状相关的候选基因ACTA2、CRTAP和SEPTIN6,为苏山猪初生体尺性状和乳头数性状的遗传改良提供了重要的分子标记。     

ACVIM Consensus Statement on Therapeutic Antimicrobial Use in Animals and Antimicrobial Resistance

The epidemic of antimicrobial resistant infections continues to challenge, compromising animal care, complicating food animal production and posing zoonotic disease risks. While the overall role of therapeutic antimicrobial use in animals in the development AMR in animal and human pathogens is poorly defined, veterinarians must consider the impacts of antimicrobial use in animal and take steps to optimize antimicrobial use, so as to maximize the health benefits to animals while minimizing the likelihood of antimicrobial resistance and other adverse effects. This consensus statement aims to provide guidance on the therapeutic use of antimicrobials in animals, balancing the need for effective therapy with minimizing development of antimicrobial resistance in bacteria from animals and humans.     

Anethole inhibits growth of recently emerged multidrug resistant toxigenic Vibrio cholerae O1 El Tor variant strains in vitro

To search natural compounds having inhibitory effect on bacterial growth is important, particularly in view of growing multidrug resistant (MDR) strains of bacterial pathogens. Like other bacterial pathogens, MDR Vibrio cholerae, the causative agent of diarrheal disease cholera, is becoming a great concern. As an approach of searching new antimicrobial agents, here, we show that anethole, a well-studied natural component of sweet fennel and star anise seeds, could potentially inhibit the growth of MDR O1 El Tor biotype, the ongoing 7th cholera pandemic variant strains of toxigenic V. cholerae. The minimum inhibitory concentration (MIC) of anethole against diverse O1 El Tor biotype strains is evaluated as 200 µg/ml. Moreover, the effect of anethole is bactericidal and exerts rapid-killing action on V. cholerae cells. This study is the first report which demonstrates that anethole, purified from natural compound, is a potent inhibitor of growth of toxigenic V. cholerae. Our data suggest that anethole could be a potential antimicrobial drug candidate, particularly against MDR V. cholerae mediated infections.     

乌鲁木齐市冬春两季宠物源葡萄球菌的耐药性及耐药基因比较

采用琼脂稀释法,检测从乌鲁木齐市部分宠物医院冬季和春季分离鉴定的154株宠物源葡萄球菌(冬季75株、春季79株)对临床常用的12种抗菌药物(阿米卡星、克林霉素、硫酸庆大霉素、氟苯尼考、四环素、利福平、恩诺沙星、青霉素、苯唑西林、阿莫西林/克拉维酸、头孢噻呋、左氧氟沙星)的耐药性;通过卡方检验,比较供试菌耐药性差异;采用PCR方法,检测葡萄球菌的5类9种耐药基因。对抗菌药物的耐药结果显示:冬季葡萄球菌对苯唑西林和青霉素的耐药率高于90.0%,对头孢噻呋和四环素的耐药率高于50.0%;春季葡萄球菌对左氧氟沙星耐药率达92.4%,对苯唑西林和氟苯尼考耐药率高于80.0%。卡方检验结果显示:冬季葡萄球菌仅对苯唑西林的耐药率显著高于春季葡萄球菌(P0.05);春季葡萄球菌对氟苯尼考、利福平、左氧氟沙星、恩诺沙星和阿莫西林/克拉维酸的耐药率均显著高于冬季葡萄球菌(P0.05)。多药耐药差异性结果显示:冬季葡萄球菌多药耐药集中在1～3耐;春季葡萄球菌多药耐药集中在4、6、9耐。基因检测结果显示:冬季葡萄球菌主要检出的基因有ermB(40.0%,30/75)和fexA(22.7%,17/75);春季葡萄球菌主要检出的基因有fexA(39.3%,31/79)和femA(20.3%,16/79),冬、春季葡萄球菌均未检出cfr、fexB和tetA基因。